HER2 positive breast cancer

被引：0
作者：
Gianni, Luca
Bianchini, Giampaolo
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-ED11-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ED11-2
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
    Stanowicka-Grada, Malwina
    Senkus, Elzbieta
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (11) : 1633 - 1650
  • [42] Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer
    Guarneri, V.
    Barbieri, E.
    Dieci, M. V.
    Piacentini, F.
    Conte, P.
    CANCER TREATMENT REVIEWS, 2010, 36 : S62 - S66
  • [43] HER2 mutation status in Japanese HER2-positive breast cancer patients
    Yumi Endo
    Yu Dong
    Naoto Kondo
    Nobuyasu Yoshimoto
    Tomoko Asano
    Yukari Hato
    Mayumi Nishimoto
    Hiroyuki Kato
    Satoru Takahashi
    Ryoichi Nakanishi
    Tatsuya Toyama
    Breast Cancer, 2016, 23 : 902 - 907
  • [44] HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Zhang, Chao
    Suo, Aili
    Shi, Qiuying
    Wei, Zhimin
    Li, Zaibo
    Krishnamurti, Uma
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2019, 99
  • [45] HER2 mutation status in Japanese HER2-positive breast cancer patients
    Endo, Yumi
    Dong, Yu
    Kondo, Naoto
    Yoshimoto, Nobuyasu
    Asano, Tomoko
    Hato, Yukari
    Nishimoto, Mayumi
    Kato, Hiroyuki
    Takahashi, Satoru
    Nakanishi, Ryoichi
    Toyama, Tatsuya
    BREAST CANCER, 2016, 23 (06) : 902 - 907
  • [46] Understanding the spectrum of HER2 status in breast cancer: From HER2-positive to ultra-low HER2
    Ahuja, Sana
    Khan, Adil Aziz
    Zaheer, Sufian
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 262
  • [47] Characteristics, treatment and outcomes of HER2 positive male breast cancer
    Esposito, Adrienne
    Ablah, Elizabeth
    Okut, Hayrettin
    Tenofsky, Patty L.
    AMERICAN JOURNAL OF SURGERY, 2023, 225 (03) : 489 - 493
  • [48] HER2 and response to paclitaxel in node-positive breast cancer
    Nash, Irwin
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (02) : 198 - 198
  • [49] Adding Pertuzumab to Trastuzumab and Taxanes in HER2 positive breast cancer
    Gleeson, Jack Patrick
    Keegan, Niamh M.
    Morris, Patrick G.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (03) : 251 - 262
  • [50] HER2 positive breast cancer: is there a preventive role of cardioprotective drugs?
    Martins De Carvalho, M.
    Pinto, R. A.
    Proenca, T.
    Costa, I.
    Torres, S.
    Resende, C. X.
    Grilo, P. D.
    Amador, A. F.
    Costa, C.
    Calvao, J.
    Sousa, C.
    Paiva, M.
    Macedo, F.
    Marques, C.
    Cabrita, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2872 - 2872
12345